Kenya’s Ministry of Health Launches Nationwide HPV Vaccination Campaign

BUNGOMA — In a significant public health initiative, the Ministry of Health announced plans to launch a nationwide Human Papillomavirus (HPV) vaccination program across all 47 counties, targeting the reduction of cervical cancer cases in Kenya.

According to Kenya News Agency, Chief Executive Officer of the National Cancer Institute, the government will cover the costs of the vaccine, addressing and dispelling myths surrounding its use and affirming its safety.

Dr. Melly revealed that annually, 44,000 Kenyans are diagnosed with cancer, with women constituting the majority of these cases through cervical cancer diagnoses. During a session with Community Health Promoters (CHP) in Bungoma, he emphasized the World Health Organization’s recommendation for the vaccine to be administered to girls aged 15 years. Additionally, women aged 35 to 45 will undergo screening, with those testing positive for HPV receiving necessary treatment.

Highlighting the preventable nature of cervical cancer through early detection, screening, and treatment, Dr. Melly urged women to participate actively in the vaccination effort. He noted the dire statistics that annually, 3,600 Kenyan women are diagnosed with cervical cancer, with 67% succumbing to the disease. This mortality rate, he argued, could be significantly reduced through increased awareness, screening, and vaccination.

Furthermore, the Ministry of Health intends to train Community Health Promoters on cancer education, equipping them to disseminate vital information at the community level. This move aims to enhance grassroots awareness and participation in the fight against cervical cancer, leveraging the vaccination campaign as a key preventive measure. HPV, identified as a sexually transmitted infection, represents a critical target in the country’s broader public health strategy to combat cervical cancer.